Pyoderma gangrenosum and tumor necrosis factor a agents

Cutis

Volumn 92, Issue 4, 2013, Pages

  Rallis, Efstathios ^a   Mathioudaki, Koumantaki ^b   Stavropoulos, Tsiatoura ^b   Katsambas, ^b  

^a Veterans Administration Hospital NIMTS   (Greece)

^b ANDREAS SYGROS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGICAL AGENT; IMMUNOGLOBULIN G; INFLIXIMAB; METHOTREXATE; MONOCLONAL ANTIBODY; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

CASE REPORT; CROHN DISEASE; DRUG ANTAGONISM; HUMAN; LETTER; MALE; MIDDLE AGED; PATHOLOGY; PYODERMA GANGRENOSUM; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; CROHN DISEASE; DERMATOLOGIC AGENTS; HUMANS; IMMUNOGLOBULIN G; MALE; METHOTREXATE; MIDDLE AGED; PYODERMA GANGRENOSUM; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84886737262     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Reguiaï Z, Grange F. The role of anti-tumor necrosis factor-a therapy in pyoderma gangrenosum associated with inflammatory bowel disease. Am J Clin Dermatol. 2007;8:67-77.
2. Powell FC, Hackett BC. Pyoderma gangrenosum. In: Wolff K, Goldsmith L, Katz SI, eds. Fitzpatrick's Dermatology in General Medicine. 7th ed. New York, NY: McGraw Hill; 2007:296-302.
3. Ruocco E, Sangiuliano S, Gravina AG, et al. Pyoderma gangrenosum: an updated review [published online ahead of print March 11, 2009]. J Eur Acad Dermatol Venereol. 2009;23:1008-1017.
4. Charles CA, Leon A, Banta MR, et al. Etanercept for the treatment of refractory pyoderma gangrenosum: a brief series. Int J Dermatol. 2007;46:1095-1096.
5. Alkhouri N, Hupertz V, Mahajan L. Adalimumab treatment for peristomal pyoderma gangrenosum associated with Crohn's disease. Inflamm Bowel Dis. 2009;15:803-806.
6. Kleinpenning MM, Langewouters AM, Van De Kerkhof PC, et al. Severe pyoderma gangrenosum unresponsive to etanercept and adalimumab [published online ahead of print August 1, 2010]. J Dermatolog Treat. 2011;22:261-265.